NOX5, a New “Radical” Player in Human Atherosclerosis?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.  by Schulz, Eberhard & Münzel, Thomas
N
i
E
T
M
D
d
o
c
d
i
d
d
R
a
R
i
(
p
c
N
p
a
p
i
t
b
m
c
i
i
r
o
t
i
u
R
t
t
o
f
p
o
c
r
v
f
w
u
e
a
p
p
e
a
u
c
p
p
m
N
i
s
(
p
k
i
b
g
i
t
e
e
T
h
i
N
t
e
j
c
m
s
p
f
*
v
A
G
m
Journal of the American College of Cardiology Vol. 52, No. 22, 2008
© 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2008.08.040EDITORIAL COMMENT
OX5, a New “Radical” Player
n Human Atherosclerosis?*
berhard Schulz, MD,
homas Münzel, MD, FAHA
ainz, Germany
uring the last 20 years, a large body of evidence has
efined a causal role for oxidative stress in the development
f vascular disease. Reactive oxygen species (ROS) are
ontinuously being produced in the vasculature, and in low
oses they even may be essential because they act as
mportant signalling molecules (1). However, known car-
iovascular risk factors such as smoking, hypertension,
iabetes, and hypercholesterolemia will lead to an increased
OS flux from all layers of the vascular wall, thereby
ccelerating the atherosclerotic process. So far, numerous
OS sources in the vasculature have been identified, includ-
ng the reduced nicotinamide dinucleotide phosphate
NADPH) oxidase, mitochondria, xanthine oxidase, uncou-
See page 1803
led endothelial nitric oxide synthase (eNOS), and cyto-
hrome P450 (2). Among all potential ROS sources, the
ADPH oxidase has, since the early 1990s, attracted
articular interest. Historically, this oxidase was discovered
s a part of the neutrophil bactericidal response, when it
roduces large amounts of superoxide anions (3). Its absence
s associated with chronic granulomatous disease, a condi-
ion that does not allow proper elimination of pathogen
acteria. In the atherosclerotic process, invasion of inflam-
atory cells is a common feature and contributes to in-
reased ROS flux. However, with the discovery of vascular
soforms of the neutrophil NADPH oxidase (4), a new era
n the field of vascular oxidative stress research began.
The extraordinary importance of the NADPH oxidase
egarding vascular oxidative stress is underlined by two
bservations. First, vascular NADPH oxidases were found
o contribute largely to the overall vascular ROS production
n vivo (5). Second, other potential ROS sources such as the
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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ermany. This work was supported by a grant from the Deutsche Forschungsge-
einschaft SCHU 1486/2-1 to Dr. Schulz.ncoupling of eNOS or xanthine oxidase require a primary
OS generating system, and NADPH oxidases may serve
o produce these “kindling radicals” (6,7).
The majority of ROS is produced by single electron
ransfer from NADPH to molecular oxygen (that is why
ne calls it NADPH oxidase), resulting in superoxide anion
ormation. The latter can be transformed into hydrogen
eroxide by endogenous superoxide dismutase or spontane-
us dismutation. Vascular damage by increased ROS can be
aused by several mechanisms: superoxide anions react
apidly with nitric oxide, leading to the degradation of this
ascular protective molecule and simultaneously to the
ormation of the highly reactive intermediate peroxynitrite,
hich was recently identified as being responsible for eNOS
ncoupling (8). Moreover, ROS will lead to increased
xpression of transcription factors, inflammatory cytokines,
nd adhesion molecules; they promote smooth muscle
roliferation and migration and, therefore, initiate and
erpetuate the atherosclerotic process.
Although the NADPH oxidase (NOX) isoform NOX4 is
xpressed constitutively, all other NOX isoforms require
ctivation by an isoform-specific assembly of different sub-
nits. As the prototype of all NADPH oxidases, NOX2
onsists of 2 membrane-associated proteins, NOX2 and
22phox, whereas on activation the cytosolic components
47phox, p67phox, and rac-GTPase are translocated to the
embrane to form a complete, superoxide anion generating
ADPH oxidase complex. So far, at least 7 different NOX
soforms have been described (NOX1-5, DUOX 1/2), and
o far 4 of them have been found in the vascular wall
NOX1, NOX2, NOX4, NOX5), whereas their expression
attern is different in each layer of the vascular wall (Fig. 1) (9).
In this issue of the Journal, Guzik et al. (10) extend our
nowledge about the expression and distribution of NOX5
n vascular tissue. So far, the characterization of NOX5 has
een hampered by the fact that rodents lack the NOX5
ene. It is known that NOX5 is a calcium-dependent NOX
soform that does not require other subunits for its activa-
ion. In their current work, Guzik et al. (10) studied the
xpression of NOX5 in human coronary arteries from
xplanted hearts and in endothelial cells from human origin.
hey found that NOX5 is expressed predominantly in the
ealthy endothelium, whereas its expression was sharply
ncreased in atherosclerotic vessels. In atherosclerosis,
OX5-dependent ROS production largely contributed to
he overall NADPH oxidase activity, and interestingly, its
xpression is considerably increased in smooth muscle ad-
acent to atherosclerotic plaques. Recent studies also indi-
ate that NOX5 can directly activate eNOS, all of which
ay be considered as a compensatory response to increased
uperoxide production (11), ultimately leading to enhanced
eroxynitrite formation and therefore to endothelial dys-
unction (12).
Despite these intriguing observations, several issues re-
ain unresolved. First, it is unclear whether the observed
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November 25, 2008:1810–2 NOX5 and Human Atherosclerosisncrease in NOX5 expression causally contributes to vascu-
ar pathology or is just an epiphenomenon. The large
ontribution to the overall NADPH-oxidase–triggered
OS production in the current work and its localization in
he endothelium might support a causal role for NOX5 in
he atherosclerotic process. It is tempting to speculate that
OX5 might affect plaque rupture, given its increased
xpression in areas close to atherosclerotic plaques. We
now today that ROS generated by NADPH oxidases
articipate in diverse signalling events, and therefore, their
ascular and subcellular location plays a crucial role regard-
ng the function of different NOX isoforms. For example,
ndothelial NOX2 is known to account for a ROS-
ependent decrease of NO bioavailability; NOX4 is located
n the endoplasmatic reticulum and influences ROS-
ependent signalling processes such as regulation of phos-
hatases (1). Also the kind of ROS that are produced by
ADPH oxidases, in particular superoxide anion versus
ydrogen peroxide, depends on subcellular location and
ndividual NOX protein conformation. It is still a matter of
ebate whether hydrogen peroxide is directly produced by
he NADPH oxidase or is just a consequence of rapid
ismutation of superoxide anion (by superoxide dismutase
Figure 1 Structure of Vascular NADPH Oxidases
The nicotinamide dinucleotide phosphate (NADPH) oxidase (NOX) isoforms being e
and NOX4 isoforms require the subunit p22phox to form functional reactive oxygen
NOX5. The NOX1 NADPH oxidase associates with 2 cytosolic factors (p47phox and
p47phox and p67phox, whereas NOX4 has at present no regulatory subunits; NOX
oxide (O2
·) is generated via an electron shuttle from NADPH to oxygen, which is w
endothelial growth factor; VSMC  vascular smooth muscle cells.r spontaneously). This dismutation might also relate to oositively charged heme groups in the NOX5 protein,
hich retain the superoxide anion until its dismutation to
ydrogen peroxide occurs. Nevertheless, the predominant
roduction of hydrogen peroxide has been described for
OX4 and seems to prevail also in NOX5-dependent ROS
eneration. To understand the cellular function of NOX5,
nformation about its subcellular expression pattern will be
elpful.
The calcium-dependent activation of NOX5 is unique for
ll vascular NADPH oxidases and might point to a specific
unction. Also, this property of NOX5 may allow pharma-
ological interventions, because calcium antagonists are
vailable and might be a suitable tool for modulating
OX5-dependent ROS production. However, this aspect is
ot as straightforward as it seems because: 1) endothelial
ells lack voltage-dependent calcium channels and are there-
ore not susceptible to a therapy with calcium-antagonists
uch as amlodipine; and 2) even if NOX5 expression occurs
n smooth muscle cells during atherosclerosis, calcium
ntagonists may also affect the activity of other NOX
soforms, for example, by decreased activation of calcium-
ependent protein kinases.
Taken together, the current study by Guzik et al. (10)
ed in vascular tissue include NOX1, NOX2, NOX4, and NOX5. The NOX1, NOX2,
ies–generating NADPH oxidase enzymes; this is, however, not the case for
1) as well as the small-molecular-weight molecule Rac; NOX2 is regulated by
nique because its activity is regulated by binding to calcium. The oxidizing super-
e calls it the NADPH oxidase. ER  endoplasmatic reticulum; VEGF  vascularxpress
spec
NOXA
5 is u
hy onpens a new chapter in NOX5 research by identifying this
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NOX5 and Human Atherosclerosis November 25, 2008:1810–2xidase as a new “radical player.” Unfortunately, interven-
ional studies with murine knockout models are not feasible
iven the natural lack of the NOX5 gene in rodents.
herefore, future investigations will be complicated by the
hoice of an adequate animal model or the use of human
issue. Because NOX5 is the only calcium-dependent vas-
ular NOX isoform so far, exciting studies with the use of
alcium antagonists are warranted and will reveal whether
his approach can be used to modify NOX5 activity, with all
f the caveats mentioned herein.
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